Emory University School of Medicine Researcher Adds New Study Findings to Research in Lymphoma [Extended Follow up and Immune Alterations in Patients with Classic Hodgkin Lymphoma (cHL) Treated with Frontline Single Agent Pembrolizumab Followed ...]
- Bin Zhang
Press/Media: Press / Media